HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids 
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
BURLINGTON, Mass., Nov. 08, 2016 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three investor conferences in November.
David Roberts, President, is scheduled to present at the Stifel Healthcare Conference in New York on Wednesday, November 16 at the Lotte New York Palace Hotel. The Company’s presentation is scheduled to begin at 11:45 am ET.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Three Part Advisors Southwest IDEAS Conference in Dallas on Wednesday, November 16 at the InterContinental Dallas Hotel. The Company’s presentation is scheduled to begin at 11:20 am CT.
George W. LeMaitre, Chairman & CEO, is scheduled to present at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York on Thursday, November 17 at the Westin Grand Central Hotel. The Company’s presentation is scheduled to begin at 3:00 pm ET.
For more information or to register, please visit the conference websites at www.stifel.com, www.threepartadvisors.com and www.canaccordgenuity.com.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Steven Chehames Investor Relations +1-781-425-1659 [email protected] http://www.lemaitre.com
